BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
-1.26%
-7.50p
586.50p
17:18 04/05/16

   Spread betting | CFDs | Stockbroking   Trade now with IG Sponsored by IG. Losses can exceed deposits

586.50p
17:18 04/05/16
DAILY VARIATION
-1.26%
-7.50p
VOLUME
394,486
REAL TIME BATS
586.50p
17:18 04/05/16
-1.26%
-7.50p
DATA
52 Week High
784.00p
52 Week Low
520.50p
Shares Issued
382.99m
Market Cap
£2,246.25m
RiskGrade
n/a
Beta
0.69
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 9.5% 19.6%
ROCE 26.7%
Latest F'cast
P/E 37.4 26.3
PEG 4.5 1.6
Pr/Revenue 6.1 4.6
Pr/Book 3.0
Latest F'cast
Revenue 26.6% -6.3%
PBT -19.8% n/a
EPS 8.3% -27.6%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2012-03-31 197.00 23.00 11.40p 29.3 0.0 1,040% n/a 0.0%
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2016-03-31 429.02 71.58 19.24p 30.5 1.4 23% 0.00p 0.0%
2017-03-31 493.09 96.51 22.44p 26.3 1.6 17% 0.00p 0.0%
2018-03-31 548.28 124.09 28.02p 21.5 0.9 25% 0.00p 0.0%

Regulatory News

slide to see more
Holding(s) in Company 25-Apr-16 14:46
Blocklisting Interim Review 05-Apr-16 13:13
Close Period Statement 05-Apr-16 07:03

Newspaper Links

No results found
No results found